Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genitourinary rhabdomyosarcoma.

W E Kaplan, C F Firlit, R M Berger

    The Journal of Urology
    |July 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Treatment for pediatric pelvic rhabdomyosarcoma has evolved. Chemotherapy, with limited surgery and radiation, is now an effective cornerstone, reducing the need for extensive pelvic exenteration in most cases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ureterocystoplasty: indications for a successful augmentation.

    The Journal of urology·2003
    Same author

    The semi-elective use of the pulmonary artery flotation catheter in children with progressive pulmonary hypertension or left ventricular dysfunction.

    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2003
    Same author

    Snare retrieval of intracranial thrombus in patients with acute stroke.

    Journal of vascular and interventional radiology : JVIR·2002
    Same author

    [Primary pulmonary hypertension: new treatment options].

    Nederlands tijdschrift voor geneeskunde·2001
    Same author

    Extraperitoneal placement of renal allografts in children weighing less than 15 kg.

    The Journal of urology·2001
    Same author

    Does reversal of ischemia on diffusion-weighted imaging reflect higher apparent diffusion coefficient values?

    Journal of neuroimaging : official journal of the American Society of Neuroimaging·2001
    Same journal

    On the Memoryless Property in Markov Models for NMIBC Cost-Effectiveness Analysis.

    The Journal of urology·2026
    Same journal

    Multi-institutional Assessment of Performance Metrics for MRI-targeted Transperineal Prostate Biopsy.

    The Journal of urology·2026
    Same journal

    Urinary Supersaturation in a Randomized Trial among Individuals with Recurrent Nephrolithiasis comparing Empiric versus Selective Preventive Therapy: The URINE Trial.

    The Journal of urology·2026
    Same journal

    The FDA Should Allow More BCG Strains into the US Market: How Recent Landmark Trials Expose a Regulatory Paradox.

    The Journal of urology·2026
    Same journal

    Let's Shift the Focus from Death to Life after Fournier's Gangrene.

    The Journal of urology·2026
    Same journal

    Endourology and Nephrolithiasis.

    The Journal of urology·2026
    See all related articles

    Area of Science:

    • Pediatric Oncology
    • Surgical Oncology
    • Medical Oncology

    Background:

    • Rhabdomyosarcoma is the most common pediatric soft tissue malignancy, frequently involving the pelvis.
    • Treatment strategies for pelvic rhabdomyosarcoma remain debated, with varying approaches including pelvic exenteration, radiation, and chemotherapy.
    • Paratesticular rhabdomyosarcoma has a more established combined treatment modality.

    Purpose of the Study:

    • To evaluate and compare treatment regimens for genitourinary rhabdomyosarcoma in children.
    • To assess the efficacy of different treatment strategies for pelvic rhabdomyosarcoma, specifically comparing early and later treatment series.
    • To determine if chemotherapy can be the cornerstone of treatment, minimizing extensive surgical interventions.

    Main Methods:

    Related Experiment Videos

    • Retrospective analysis of 19 children diagnosed with rhabdomyosarcoma, including 17 with pelvic and 2 with paratesticular disease.
    • Division of pelvic rhabdomyosarcoma patients into two series: an early series (pelvic exenteration ± chemotherapy) and a later series (chemotherapy-predominant treatment).
    • Evaluation of patient outcomes based on treatment received, including survival rates and disease progression.

    Main Results:

    • In the early series (n=7), 3 of 7 children survived after pelvic exenteration with or without chemotherapy.
    • In the later series (n=10), none underwent pelvic exenteration; 8 of 9 eligible patients survived with chemotherapy or chemotherapy and biopsy, with only one Stage IV death.
    • Outcomes suggest improved survival and reduced surgical morbidity with the later, chemotherapy-focused approach.

    Conclusions:

    • Pelvic rhabdomyosarcoma can be effectively treated with chemotherapy as the cornerstone, supplemented by limited surgery and radiation.
    • Extensive pelvic exenteration is now reserved for a select few patients with pelvic rhabdomyosarcoma.
    • The shift towards less invasive, chemotherapy-centric treatment has improved outcomes for pediatric pelvic rhabdomyosarcoma.